Literature DB >> 25576754

Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.

Yvette P Y Leung1, Gilaad G Kaplan2, Stephanie Coward3, Divine Tanyingoh3, Bonnie J Kaplan4, David W Johnston5, Herman W Barkema6, Subrata Ghosh1, Remo Panaccione1, Cynthia H Seow7.   

Abstract

BACKGROUND AND AIMS: Women with inflammatory bowel disease (IBD) may be at higher risk of adverse pregnancy outcomes. This study compared perinatal outcomes in women with and without IBD.
METHODS: The population-based Data Integration, Measurement, and Reporting (DIMR) administrative discharge database was used to identify women (≥18 years of age) in Alberta, Canada, with IBD who delivered a baby between 2006 and 2009 inclusive. Women without IBD were randomly sampled and matched in a 3:1 ratio to IBD cases by age at conception (±1 year). Odds ratios of gestational diabetes, preterm birth, low birth weight, cesarean section, and neonatal intensive care unit admission were calculated.
RESULTS: One hundred and sixteen IBD patients were age-matched to 381 pregnant women without IBD. Gestational diabetes, preterm birth, and cesarean section were more common in women with IBD compared with controls (6.9 versus 1.8%, p = 0.03; 12.9 versus 0.3%, p < 0.0001; 43.1 versus 21.0%, p = 0.009, respectively). On multivariate analysis, women with IBD were independently more likely to have gestational diabetes (odds ratio [OR] = 4.3; 95% confidence interval [CI] 1.2-16.3), preterm birth (OR = 19.7, 95% CI 2.2-173.9), and to deliver by cesarean section (OR = 2.7, 95% CI 1.6-4.6) after adjusting for age and smoking status.
CONCLUSION: Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with IBD. Furthermore, IBD patients are at higher risk of preterm delivery and are more likely to undergo cesarean section compared with a healthy age-matched population. The finding of a higher risk of gestational diabetes is a novel finding not previously reported in the IBD literature.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; Pregnancy; gestational diabetes; preterm birth; ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 25576754     DOI: 10.1093/ecco-jcc/jjv006

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

Review 1.  A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes.

Authors:  Gretchen Bandoli; Kristin Palmsten; Chelsey J Forbess Smith; Christina D Chambers
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 2.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

Review 3.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

4.  Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.

Authors:  Kristin Palmsten; Matthieu Rolland; Mary F Hebert; Megan E B Clowse; Michael Schatz; Ronghui Xu; Christina D Chambers
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-28       Impact factor: 2.890

Review 5.  Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric.

Authors:  Siddharth Singh; Sherman Picardo; Cynthia H Seow
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382

6.  "I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.

Authors:  Kristin Palmsten; Dani Bredesen; Meghan M JaKa; Pritika C Kumar; Jeanette Y Ziegenfuss; Elyse O Kharbanda
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-12-22       Impact factor: 2.890

Review 7.  Treatment of pregnant women with a diagnosis of inflammatory bowel disease.

Authors:  Sule Poturoglu; Asli Ciftcibasi Ormeci; Ali Erkan Duman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

Review 8.  Insights into the treatment of inflammatory bowel disease in pregnancy.

Authors:  Sarah E Shannahan; Jonathan M Erlich; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2019-05-27       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.